Skip to main content
Log in

Pretravel MMR vaccination in US travellers not cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Hyle EP, et al. The Clinical Impact and Cost-effectiveness of MMR Vaccination to Prevent Measles Importations among US International Travelers. Clinical Infectious Diseases : 11 Oct 2018. Available from: URL: http://doi.org/10.1093/cid/ciy861

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pretravel MMR vaccination in US travellers not cost effective. PharmacoEcon Outcomes News 815, 27 (2018). https://doi.org/10.1007/s40274-018-5408-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5408-y

Navigation